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Abstract 
AIM: Here we studied the role of meconium in the respiratory system on live and exited newborns (weight 250-
3000 g). Throughout this study is followed the response of tracheal rings in acetylcholine and histamine in 
different molar concentrations (10
-1
, 10
-2
, 10
-3
, 10
-4
 mol/dm
3
). 
METHODS: To study the smooth tracheal musculature we used 23 tracheal preparations obtained from the 
newborns exited from meconium aspiration.  
RESULTS: Based on the functional analysis of the tracheal specimen we have concluded that the meconium 
aspiration did not change the smooth musculature response on acetylcholine and histamine when compared to 
control group, exited from lung inflammatory processes (e.g., pneumonia, bronchopneumonia, atelectasis, 
cerebral hemorrhage), where tracheal smooth musculature response is significant (P for other causes is not 
significant (P > 0.01).  
CONCLUSION: The conclusions suggest that meconium did not potentiate the constrictor action of acetylcholine 
and histamine in the tracheobronchial system and did not cause modulation of bronchomotor tonus in case of his 
aspiration. Meconium causes mild relaxation of smooth tracheal musculature with a mechanism which is not 
mediated by cyclooxygenase products, from tracheal epithelium or proteins. Also, direct activity in the smooth 
musculature of several tested acids seems to have no significant impact in increasing the tonus of respiratory 
airway of smooth tracheal musculature. 
 
 
 
 
 
 
Introduction 
 
The mechanisms which contribute to 
increasing the reactivity of respiratory airways in 
Meconium Aspiration Syndrome (MAS) are very 
unclear. Meconium is a biologically active substance 
with very powerful contractile effect in vascular and 
airway smooth musculature, composed of leukotriene, 
PAF, ET-1 etc. Meconium contains high 
concentrations of fatty acids [1] and biliary acids [2] 
that may induce contraction of smooth musculature of 
respiratory airways. This contraction depends on the 
concentration of aspirated meconium [3]. Meconium 
aspiration syndrome (MAS) is an important cause of 
mortality and respiratory morbidity in newborns 
babies. Mechanic obstruction of respiratory airways, 
dysfunction of pulmonary surfactant, pulmonary 
inflammation and vasoconstriction are pathologic 
mechanism associated with MAS syndrome. Damage 
reactivity of respiratory airways also could be 
associated with MAS syndrome [4] [5].  
The airway obstruction could affect reflexive 
alteration of bronchomotor tonus associated with 
bronchoactive substances. Interactions between 
individual pathogenetic factors are not yet known. 
Meconium is found to be present from 12 weeks of 
gestation. It is a product of amniotic fluid of fetus 
containing plaque cells of vernix caseosa secretion 
and gastrointestinal cells [6]. Meconium contains 4 
different fatty acids (e.g. Choline, henodeoxicholic 
acid and lithocholic) and minerals from witch copper, 
zinc, manganese, calcium, iron and phosphorus are 
more frequent component [7] [8]. Also contains 
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plasma proteins (alpha 1 antitrypsin) [9] [10] and other 
active substances such as interleukins IL-1β, IL-6 and 
IL8, tumor necrosis factor (TNF-alpha) [11] and 
phospholipase A2 (PLA2) [12] which may induce 
directly or indirectly pulmonary inflammation, by 
increasing production of cytokines and by activating 
white blood cells or epithelial/endothelial cells of 
lungs. In vitro exposure of meconium increase release 
of IL-8, TNF-alpha [13], endothelin-1, platelets 
activating factor (PAF), leukotrienes, thromboxane A2, 
induced of NO synthetase [14], NO [15], PLA2 and 
other substances which affect the reactivity of 
respiratory airways and inflammation. 
Recent studies of meconium aspiration in rats 
have shown the increased response of smooth 
musculature of respiratory airways to methacholine 
after seven days, and also to histamine in rabbits after 
5.5 hours from meconium application. Mechanisms of 
increased reactivity of respiratory airways in MAS 
syndrome are unknown. Direct inflammatory effects of 
meconium on the release of broncho active 
substances (PAF, leukotrienes, etc.) and hypoxia 
accompanied by oxidative damage from oxygen 
therapy may be operative in this process [12]. 
Purpose of the study is to demonstrate the 
action of meconium in newborn babes with MAS 
syndrome in the inflexion of acetylcholine and 
histamine action in the smooth musculature of the 
tracheobronchial system in alive and the dead 
newborn babes. 
 
 
Material and Methods  
 
The research was conducted in cooperation 
with the Gynecology Obstetrics Clinic, Pathologic 
Anatomy Institute and Experimental Unit of Medical 
Faculty in Prishtina, with permission of the Ethics 
Commission by respecting principles of Helsinki 
Declaration.  
Classification of tracheal preparation of 
newborn babies in different weeks of gestations is 
made by histopathological examination of tracheal 
preparation (in blocks of paraffin). The preparations 
have been stained with the standard: hematoxylin-
eosin (H & E) methods.  
Research has been conducted in 33 subjects 
of in vitro isolated tracheas of babies in different 
weeks of gestations (weight 250 to 3000 g). Tracheas 
were taken immediately after autopsies. Above 
bifurcation of the trachea were taken 6 tracheal rings 
and placed in Krebs solutions DIP (pH = 7.4). The 
water bath temperature was kept at 37
0
C, and solution 
in the bath is aerosolised continuously with a gas 
mixture (95% CO2 and 5% O2), which has flowed in 
continual mode through the bath solution. Tracheal 
rings are serially connected with each other. The 
series consisting from 6 rings are placed in the bath 
for isolated organs (volume 50 ml), so that lower part 
of the ring is connected to the holder, while the upper 
part is connected to the transducer (" Force 
transducer" Statham UC2). The smooth musculature 
response is registered in the multi-channel recorder 
(Watanabe HSE 6600). After 30 minutes is registered 
tonus of tracheal rings, then preparation is exposed to 
different molar concentration (10
-1
, 10
-2
, 10
-3
, 10
-4
, 
mol/dm
3
) of acetylcholine and histamine. Doses are 
changed every 15 minutes, while effects of broncho 
constrictor agents are followed 3 minutes, after 
application. Then preparation is rinsed several times 
with Krebs solution, before application of another 
substance.  
Results are processed with statistic computer 
program GraphPad InStat III with comparing t-test for 
two working groups. 
 
 
Results 
 
In Table 1 and Figure 1 is showed the 
acetylcholine dose response on smooth tracheal 
musculature in newborn babies of different age 
groups of meconium aspiration syndrome vs control 
group (P < 0.01). 
Table 1: Acetylcholine dose response of smooth tracheal 
musculature in newborn babes of different age groups of 
meconium aspiration syndrome MAS (Mean ± SEM) 
Groups Ach log
-4 
Ach log
-3
 Ach log
-2
 Ach log
-1
 
MAS 2.91 ± 0.98 4.79 ± 1.56 10.75 ± 3.33 19.70 ± 4.73 
Control 4.5 ± 1.53 7.18 ± 2.21 13.37 ± 3.46 23.96 ± 4.89 
 
In Table 2 and Figure 2 is showed the 
cumulative response of histamine in smooth tracheal 
musculature in newborn babies of different age 
groups of meconium aspiration syndrome vs control 
group (P < 0.01). 
 
Figure 1: the Cumulative action of acetylcholine in smooth 
musculature in newborn babes with different age groups of 
Meconium Aspiration Syndrome (Mean ± SEM) 
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Table 2: Histamine dose response of smooth tracheal 
musculature in newborn babes of different age groups of 
meconium aspiration syndrome MAS (Mean ± SEM). 
Groups Histamine log
-4 
Histamine log
-3
 Histamine log
-2
 Histamine log
-1
 
MAS 4.161 ± 1.76 8.0 ± 2.81 14.75 ± 4.04 22.0 ± 5.60 
Control 5.25 ± 1.68 10.18 ± 2.56 19.06 ± 3.72 27.08 ± 5.06 
 
Figure 3 is presented comparative effect of 
acetylcholine and histamine action in newborn babies 
of different age groups of meconium aspiration 
syndrome vs control group (P < 0.1). 
 
Figure 2: the Cumulative action of histamine in smooth tracheal 
musculature in newborn babes of different age groups of Meconium 
Aspiration Syndrome (Mean ± SEM) 
 
 
Discussion  
 
The studies of newborn babies affected with 
MAS during neonatal period have shown the 
abnormality of functionally pulmonary tests, 
diminished obstruction of respiratory airways, an 
episode of bronchospasm, and need for 
bronchodilator therapy.  
 
Figure 3: the Cumulative action of histamine and acetylcholine in 
smooth tracheal musculature in newborn babes of different age 
groups of Meconium Aspiration Syndrome (Mean ± SEM) 
 
Progressive lung inflammation may increase 
the reactivity of respiratory airways. Thus the use of 
bronchodilators together with anti-inflammatory drugs 
may be useful in MAS syndrome. Meconium stasis of 
the amniotic fluid happens at least in 8% of all births. 
Incidence varies from 5-8 % before 39 weeks of 
gestation. Incidence could increase by 12 % after 39 
weeks of gestation [15]. Prematurity is not a risk 
factor. MAS is very rare in newborn babes before 34 
weeks of gestation. Meconium stasis presents a risk 
for newborn babes; MAS proceed in 10-30% and 19-
34% cause mortality. Risk factors in MAS syndrome 
include newborn babes 1-3 weeks after birth date 
period, maternal diabetes, hypertension in gestation, 
difficult births, respiratory distress syndrome (RDS) in 
newborn babes, intrauterine hypoxia [16]. 
Symptoms and signs of MAS syndrome 
include tachypnea, nasal secretion, retraction, 
cyanosis or increased desaturation, also heavy stasis 
in umbilical cordon with skin spots. Meconium stasis 
can be noticed in oropharynx, larynx and trachea. The 
prophylactic suction of nose and mouth before the 
birth of body of the babes decreases the risk of MAS 
[17]. 
Recently, new therapeutic strategy for the 
treatment of MAS is suggested [18] including anti-
inflammatory drugs, such as antagonists of 
prostaglandins, high-frequency ventilation, exogenous 
surfactant, nitric oxide and water inhalation [18]. 
 The rings of tracheal tissue and lungs of 
guinea pigs are incubated for one hour in a water bath 
for isolated organs, in three different concentrations 
with human meconium to investigate whether there is 
a connection between the cumulative dosages of 
acetylcholine, histamine and meconium 
concentrations and contraction response [19]. Current 
studies show that the contractile response of the rings 
of tracheal and lungs tissue gradually increases with 
cumulative doses of acetylcholine and histamine in 
different concentrations of meconium and control 
condition [19]. However, there is no complete 
response in decreased concentration of meconium, 
which has lower tracheal reactivity to histamine and 
acetylcholine [19]. High concentration of meconium 
tends to increase tracheal reactivity. Incubation in a 
lower concentration of meconium 1 mg/ml in rabbit 
trachea act by lowering reactivity in vitro of 
acetylcholine and histamine [19]. In vitro relaxation of 
smooth tracheal musculature has been demonstrated 
in rats [20], but relaxation response increases with 
increasing of meconium concentration. Presence of 
reduced concentration of meconium in amniotic fluid 
may present a sign of physiologic maturity in newborn 
babes and do not present inflammatory response of 
tissues. On the other side, a high concentration of 
meconium may cause harmful changes resulting in 
inflammations and related to constriction of vascular 
and respiratory airways of the smooth musculature. 
While a lower concentration of meconium increases 
secretion of surfactant in isolated alveolar tip II cell 
[20] and inhibit oxidative blast of neutrophils and 
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phagocytosis [21]. This antioxidative capability of 
meconium could be partially responsible for the lower 
incidence of MAS syndrome in case of amniotic fluid 
aspiration of newborn babes. 
In vitro condition, the aspiration of 20% of 
meconium in rats significantly increases the response 
of the respiratory airways to methacholine after 7 days 
and is associated with the lymphocytic and 
eosinophilic inflammation, metaplasia of goblet cells 
and increased concentrations of IL-5 and IL-3 in 
bronchoalveolar wash [1]. Is noticed progression of 
the polymorphonuclear inflammation in ventilated rats 
for 5.5 hours after inhalation of meconium, who also 
was associated with increased tracheal reactivity to 
histamine [2]. The above results suggest that the 
contraction of smooth musculature of the respiratory 
airways is associated with concomitant mechanisms 
at MAS syndrome, such hypoxia, cytokine production 
and the reactive products during inflammations.  
There is no full correlation between contractile 
response and meconium concentration. Tracheal 
reactivity of the respiratory airways to the cumulative 
dosage of histamine and acetylcholine increases with 
increased concentration of meconium, but the 
reactivity of lung tissue tends to decreases. 
Mechanisms of reactivity in affected respiratory 
airways in MAS syndrome are unclear, and further 
experiments show for constrictor response of smooth 
musculature of the respiratory airways to meconium. 
In the present studies, during increased 
concentrations of meconium, reactivity response of 
smooth tracheal musculature to the acetylcholine and 
histamine is shown with a tendency to partial 
decreases depending from increases dosage of these 
mediators. The different responses may be related to 
the duration of exposure to meconium. Exposure for a 
short time in vitro may present vasodilator and 
bronchodilator effects, while exposure for a long time 
may have mainly constrictor effects in smooth 
musculature that depends on the time of inhibiting 
medium. For a better understanding of above 
mechanisms, incubation for a short period in vitro of 
pulmonary rings and blood vessels in different 
meconium concentrations would be necessary. 
Based on the results obtained experimentally 
can be concluded that: 
Tracheal smooth musculature response in 
MAS syndrome to acetylcholine in cases that have 
exited without aspiration of amniotic fluid is significant 
(P < 0.01). 
Meconium in MAS syndrome does not 
potentiate the constrictor action of acetylcholine in 
smooth tracheal musculature insignificant way (P > 
0.1). 
Tracheal smooth musculature response in 
MAS syndrome to histamine in cases that have not 
exited from meconium aspiration (but for other 
reasons) is significant (P < 0.01). 
Meconium in MAS syndrome does not 
potentiate the constrictor action of histamine 
compared to group control (P > 0.1). 
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